Keosys-Blog-Graphic-1

The Keosys Blog

Expert insights into medical imaging in clinical trials.
Keosys
Interview: Helen Blanco talks about innovation in oncology space
With her large experience in the pharmaceutical industry, Helen Blanco..
From Cheson 1999 to RECIL: Evolution of the Response Assessment Criteria in Lymphoma
Lymphoma can be defined as a type of cancer that affects the lymphatic system,..
Keosys
3 Things your Imaging CRO Needs in 2023
Imaging CROs provide critical expertise that can help to optimize clinical..
Keosys
Imaging CROs Role in Clinical Research with Infographic
The use of imaging endpoints in clinical trials has steadily grown over the..
What Does a First-Rate Medical Imaging CRO Look Like in 2021?
Today, medical imaging CROs (ICROs) are more likely than ever to be a key asset..
The Power of Flexible, Independent Central Review in Clinical Trials
Medical imaging has been used for decades in the evaluation and development of..
Four Key Things to Consider When Selecting an Imaging CRO
In the clinical study process, medical imaging is becoming more common as..
What is a Medical Imaging CRO?
In the life science industry, there are biopharma companies who carry out..
The Benefits of an Integrated Medical Imaging System in Clinical Trials
If you have a friend that lives out of town and has an upcoming birthday, you..

More Posts

New call-to-action